Research Article

Impact of Perioperative Blood Transfusion on Postoperative Complications and Prognosis of Gastric Adenocarcinoma Patients with Different Preoperative Hemoglobin Value

Table 1

Comparison of clinicopathological features of all transfused and nontransfused patients.

CategoriesTransfusedNontransfused value
(%) (%)

AgeMean ± SD58.4 ± 11.755.9 ± 11.50.001

GenderMale244 (70.7)605 (70.8)0.967
Female101 (29.3)245 (29.2)

Combined organ resectionYes41 (11.9)31 (3.6)<0.001
No304 (88.1)823 (96.4)

Type of gastrectomyDG193 (55.9)519 (60.8)0.055
TG86 (24.9)160 (18.7)
PG66 (19.2)175 (20.5)

Operation approachOpen surgery325 (94.2)725 (84.9)<0.001
Laparoscopic assisted20 (5.8)129 (15.1)

Concomitant diseasesYes182 (52.8)403 (47.2)0.081
No163 (47.2)451 (52.8)

Longitudinal locationU72 (20.9)221 (25.9)0.004
M63 (18.3)102 (11.9)
L202 (58.6)523 (61.2)
Whole8 (2.2)8 (1.0)

Differentiation gradeWell/moderate48 (13.9)171 (20.0)0.013
Poor/undifferentiated297 (86.1)683 (80.0)

Macroscopic typeTypes 0–2210 (60.9)569 (66.6)0.058
Types 3–4135 (39.1)285 (33.4)

Tumor size (cm)Mean ± SD5.7 ± 2.64.6 ± 2.5<0.001
≤4.5120 (34.8)461 (54.0)<0.001
>4.5225 (65.2)393 (46.0)

T stageT128 (8.1)192 (22.5)<0.001
T2 37 (10.7)121 (14.2)
T314 (4.1)44 (5.2)
T4266 (77.1)497 (58.1)

N stageN084 (24.3)319 (37.4)<0.001
N169 (20.0)154 (18.0)
N266 (19.1)168 (19.7)
N3a90 (26.1)157 (18.4)
N3b37 (10.5)56 (6.5)

TNM stageI/II108 (31.3)410 (48.0)<0.001
III237 (68.7)444 (52.0)

Operation time (min)Mean ± SD241.0 ± 61.9232.8 ± 49.90.169

Intraoperative blood loss (mL)Mean ± SD528.7 ± 282.2414.2 ± 194.3<0.001

Postoperative complicationsStomach without tension2 (0.6)19 (2.2)0.002
Wound infection7 (2.0)10 (1.2)
Anastomotic leakage8 (2.3)6 (0.7)
Bleeding9 (2.6)3 (0.4)
Pulmonary infection65 (18.8) 117 (13.7)
Others14 (4.1)16 (1.9)
Total patients82 (23.8)152 (17.8)

Postoperative hospital stayMean ± SD12.4 ± 10.611.7 ± 9.80.261

SD: standard deviation, DG: distal gastrectomy, TG: total gastrectomy, PG: proximal gastrectomy, U: upper, M: middle, and L: lower.